focus -WSS

focus

author：Wikipedia 2025-08-25 07:30:16 - browse：3

UnitedHealth Group’s Optum subsidiary saw a lower operating margin in the second quarter due to more seniors getting care, a spike in demand for behavioral health services, and an influx of members with higher health needs.

“Those three elements, the senior trend piece, the behavioral piece, and then the effects of the strong growth is really what explains what’s going on,” UnitedHealth Group CEO Andrew Witty said on the company’s earnings call on Friday. “We’ll continue to lean into that growth very assertively.”

Minnetonka, Minn.-based UnitedHealth Group’s Optum segment, which includes its provider arm, its pharmacy benefit manager, and its data and technology arm, reported an operating margin of 6.6% in the quarter ended June 30, compared with 7.3% in the prior-year period. Leaders said the decline was within its provider arm, Optum Health.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Female surgeons have lower rates of long

WSS

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

STAT Readout: Today's biotech news includes Sana and Amylyx

Ventyx halts psoriasis drug development after lackluster trial results

Akero's treatment for NASH falls short in cirrhosis study

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

A fraught question for the kids of Alzheimer’s: Is it coming for us?

hotspot

focus

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

Better Therapeutics data on benefit with GLP

In Memoriam: Notable people who died in 2023

Carbon Health diabetes program, a test of data

Continuity nursing helped my family in our darkest PICU moments

Humana CEO Bruce Broussard to step down in 2024

Apple is now the first public company to be valued at $3 trillion

Healthy food access boosts outcomes in two studies

Alkermes shareholders re

Weight loss drugs should be covered by insurers, AMA says

entertainment

How state and local governments are sidelining science

After decades in use, heart stents finally beat placebo

Ventyx halts psoriasis drug development after lackluster trial results

After decades in use, heart stents finally beat placebo

Readout Newsletter: Zepbound, Valneva's vaccine, and more

Carbon Health diabetes program, a test of data

Wikipedia

knowledge

Wikipedia

leisure time